100 Recruiting Studies Using Cemiplimab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Cemiplimab
A Trial to Learn How the Cancer Vaccine BNT116 in Combination With Cemiplimab Works and How Safe the Combination is in Adults With Advanced Non-small Cell Lung Cancer (EMPOWERVAX Lung 1)
📍 The Oncology Institute of Hope and Innovation — Los Angeles, California
Advanced Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study of HST-1011 Given as Monotherapy and in Combination With an Anti-PD1 Antibody
📍 Florida Cancer Specialists — Sarasota, Florida
Solid Tumor, Adult
View Study & Checklist ➔Phase 2 Trial of Voyager V1 in Combination With Cemiplimab in Cancer Patients
📍 Saint John's Health Center - John Wayne Cancer Institute (JWCI) — Santa Monica, California
Melanoma
View Study & Checklist ➔THIO Sequenced With Cemiplimab in Advanced NSCLC
📍 Central Alabama Research — Birmingham, Alabama
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔Study Evaluating Cemiplimab Alone and Combined With RP1 in Treating Advanced Squamous Skin Cancer
📍 University of California San Diego — La Jolla, California
Cutaneous Squamous Cell Carcinoma
View Study & Checklist ➔A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors
📍 UCLA Hematology/Oncology — Los Angeles, California
Solid Tumor, Adult
View Study & Checklist ➔Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
📍 Froedtert Hospital & Medical College of Wisconsin — Milwaukee, Wisconsin
Invasive Breast Cancer
View Study & Checklist ➔A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery
📍 Clermont Oncology Center — Clermont, Florida
Resectable Non-small Cell Lung Cancer
View Study & Checklist ➔Androgen Deprivation, With or Without pTVG-AR, and With or Without T-Cell Checkpoint Blockade, in Patients With Newly Diagnosed, High-Risk Prostate Cancer
📍 University of Wisconsin Carbone Cancer Center — Madison, Wisconsin
Prostate Cancer
View Study & Checklist ➔Testing the Addition of Cemiplimab to Palbociclib for the Treatment of Advanced Dedifferentiated Liposarcoma
📍 University of Alabama at Birmingham Cancer Center — Birmingham, Alabama
Advanced Dedifferentiated Liposarcoma
View Study & Checklist ➔Cemiplimab, Low-Dose Paclitaxel and Carboplatin for the Treatment of Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
📍 Los Angeles General Medical Center — Los Angeles, California
Advanced Malignant Skin Neoplasm
View Study & Checklist ➔Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Non-small Cell Lung Cancer
View Study & Checklist ➔Tuvusertib (M1774) in Combination With Cemiplimab in Participants With Non-Squamous NSCLC (DDRiver NSCLC 322)
📍 UCLA Hematology and Oncology - Santa Monica — Santa Monica, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Clinical Study of Fianlimab in Combination With Cemiplimab Versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated Unresectable Locally Advanced or Metastatic Melanoma
📍 UC San Diego — La Jolla, California
Melanoma
View Study & Checklist ➔Cemiplimab in Treating Patients With Recurrent and Resectable Stage II-IV Head and Neck Cutaneous Squamous Cell Cancer Before Surgery
📍 M D Anderson Cancer Center — Houston, Texas
Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck
View Study & Checklist ➔A Phase Ib Study to Evaluate the Safety and Preliminary Efficacy of IL6-receptor Antibody Sarilumab in Combination With antiPD1 Antibody Cemiplimab for Patients With Non-small Cell Lung Cancer.
📍 M D Anderson Cancer Center — Houston, Texas
Lung Cancer
View Study & Checklist ➔A Trial to See if the Combination of Fianlimab With Cemiplimab Works Better Than Pembrolizumab for Preventing or Delaying Melanoma From Coming Back After it Has Been Removed With Surgery
📍 UC San Diego — La Jolla, California
Melanoma
View Study & Checklist ➔A Trial to Learn if Fianlimab and Cemiplimab Are Safe and Work Better Than Anti-PD1 Alone in Adult Participants With Resectable Stage 3 or 4 Melanoma
📍 UC San Diego — La Jolla, California
Melanoma
View Study & Checklist ➔The Phoenix Trial: Phase II Trial of Cemiplimab for the Non-operative Management of Localized dMMR Colon Cancer
📍 Banner - MD Anderson Cancer — Gilbert, Arizona
Colon Cancer
View Study & Checklist ➔A Study to Learn if a Combination of Fianlimab and Cemiplimab Versus Cemiplimab Alone is More Effective for Adult Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)
📍 Arizona Clinical Research Center — Tucson, Arizona
Advanced Non-Small Cell Lung Cancer
View Study & Checklist ➔Phase 1b/2 Platform Study of Select Immunotherapy Combinations in Participants With Advanced Non-small Cell Lung Cancer (NSCLC)
📍 Henry Ford Health — Detroit, Michigan
Non-small Cell Lung Cancer (NSCLC)
View Study & Checklist ➔A Study of Radiation Therapy and Cemiplimab for People With Skin Cancer
📍 University of Colorado (Data Collection Only) — Aurora, Colorado
Cutaneous Squamous Cell Carcinoma
View Study & Checklist ➔A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With Cemiplimab for Adult Participants With Advanced Cancers
📍 Valkyrie Clinical Trials — Los Angeles, California
Advanced Solid Tumors
View Study & Checklist ➔A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
📍 University of California Irvine — Orange, California
Non-Small Cell Lung Cancer
View Study & Checklist ➔Phase II Trial of Ubamatamab Alone or in Combination With Cemiplimab in MUC16-Expressing SMARCB1-Deficient Malignancies
📍 MD Anderson Cancer Center — Houston, Texas
SMARCB1-Deficient Malignancies
View Study & Checklist ➔A Trial to Learn How the Combination of Fianlimab With Cemiplimab and Chemotherapy Works Compared With Cemiplimab and Chemotherapy for Treating Adult Patients With Advanced Non-small Cell Lung Cancer
📍 Arizona Clinical Research Center — Tucson, Arizona
Non-small Cell Lung Cancer
View Study & Checklist ➔INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
📍 City of Hope — Duarte, California
Glioblastoma
View Study & Checklist ➔Study of Adjuvant Cemiplimab Versus Placebo After Surgery and Radiation Therapy in Patients With High Risk Cutaneous Squamous Cell Carcinoma
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Cutaneous Squamous Cell Carcinoma
View Study & Checklist ➔Phase II Study of Neoadjuvant Cetuximab and Cemiplimab in Patients Undergoing Surgery for HNSCC
📍 Moffitt Cancer Center — Tampa, Florida
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔A PD-1 Checkpoint Inhibitor (Cemiplimab) for High-Risk Localized, Locally Recurrent, or Regionally Advanced Skin Cancer
📍 Los Angeles County-USC Medical Center — Los Angeles, California
Recurrent Skin Squamous Cell Carcinoma
View Study & Checklist ➔Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer
📍 Roswell Park Cancer Institute — Buffalo, New York
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Bladder Urothelial Carcinoma
View Study & Checklist ➔Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma
📍 Washington University School of Medicine — St Louis, Missouri
Kidney Transplant Recipient
View Study & Checklist ➔PROSECCO: A Phase 2, Single Arm, Neoadjuvant Study Evaluating Combination Cemiplimab, Fianlimab, And Ipilimumab In Patients With Surgically Resectable Melanoma
📍 M.D. Anderson Cancer Center — Houston, Texas
Melanoma
View Study & Checklist ➔Fianlimab&Cemiplimab as TotalNeoadj The (TNT) ForMelanoma
📍 Chao Family Comprehensive Cancer Center University of California, Irvine — Orange, California
Melanoma (Skin)
View Study & Checklist ➔Cemiplimab for Clinical Stage I, 2-3.9cm, Non-Small Cell Lung Cancer
📍 Medical University of South Carolina Hollings Cancer Center — Charleston, South Carolina
Non-Small Cell Lung Cancer
View Study & Checklist ➔Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1
📍 Henry Ford Health — Detroit, Michigan
Lung Cancer (NSCLC)
View Study & Checklist ➔Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas
📍 Mayo Clinic — Rochester, Minnesota
Glioblastoma
View Study & Checklist ➔A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck
📍 The University of Chicago Medicine Comprehensive Cancer Center — Chicago, Illinois
Squamous Cell Carcinoma
View Study & Checklist ➔Zanzalintinib Plus Cemiplimab for the Treatment of BRAF Wild-Type Anaplastic Thyroid Cancer
📍 MD Anderson Cancer Center — Houston, Texas
Anaplastic Thyroid Cancer
View Study & Checklist ➔A Study of Cemiplimab and Fianlimab in People With Nasopharyngeal Carcinoma
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Nasopharyngeal Carcinoma
View Study & Checklist ➔Phase II Biomarker Study of BND-22 in Combination With Cemiplimab in Solid Tumors
📍 Md Anderson Cancer Center — Houston, Texas
Solid Tumors
View Study & Checklist ➔A Phase 1 Study of BHV-1530 in Advanced Solid Tumors
📍 Site-111 — Newport Beach, California
Solid Tumor
View Study & Checklist ➔Testing the Addition of an Anti-Cancer Drug, Cabozantinib to the Immunotherapy Drug Cemiplimab (REGN2810), in Adolescents and Adults With Advanced Adrenocortical Cancer
📍 Mayo Clinic Hospital in Arizona — Phoenix, Arizona
Locally Advanced Adrenal Cortical Carcinoma
View Study & Checklist ➔A Study of Cemiplimab and Fianlimab in People With Clear Cell Renal Cell Carcinoma
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activites) — Basking Ridge, New Jersey
Renal Cell Carcinoma
View Study & Checklist ➔Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
📍 CHUM — Montreal, Quebec
Non-Small Cell Lung Cancer
View Study & Checklist ➔Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
📍 Banner University Medical Center - Tucson — Tucson, Arizona
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8
View Study & Checklist ➔Split Course Adaptive Radiation Therapy With Pembrolizumab With/Without Chemotherapy for Treating Stage IV Lung Cancer
📍 Vanderbilt University/Ingram Cancer Center — Nashville, Tennessee
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
📍 Wake Forest Baptist Comprehensive Cancer Center — Winston-Salem, North Carolina
Nonsmall Cell Lung Cancer
View Study & Checklist ➔Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or REGN7075 in Locally Advanced Rectal Cancer
📍 Johns Hopkins Sidney Kimmel Comprehensive Cancer Center — Baltimore, Maryland
Colorectal Cancer
View Study & Checklist ➔Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma
📍 Medical Dermatology Specialists - Phoenix — Phoenix, Arizona
Cutaneous Squamous Cell Carcinoma (CSCC)
View Study & Checklist ➔Cemiplimab or Cemiplimab and Fianlimab After Stereotactic Body Radiotherapy in Clear Cell Renal Cell Carcinoma
📍 University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔A Randomized Trial of Fianlimab and Cemiplimab +/- Ipilimumab or Ipilimumab Plus Nivolumab in First-line Advanced Renal Cell Carcinoma (RCC)
📍 Georgetown University — Washington D.C., District of Columbia
Advanced Renal Cell Carcinoma (aRCC)
View Study & Checklist ➔A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
📍 University of California Los Angeles — Los Angeles, California
Head and Neck Squamous Cell Carcinoma (HNSCC)
View Study & Checklist ➔A Multicenter Phase 1b/2 Study of Adagrasib, Cetuximab, and Cemiplimab for Metastatic Colorectal Cancer Harboring KRAS G12C Mutations
📍 Massachusetts General Hospital Cancer Center — Boston, Massachusetts
Metastatic Colorectal Cancer
View Study & Checklist ➔A Ph Ib Study of REGN5678 Plus Cemiplimab in Patients With mCRPC
📍 The University of Texas M. D. Anderson Cancer Center — Houston, Texas
Prostate Cancer
View Study & Checklist ➔Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
📍 University of Kentucky Chandler Medical Center — Lexington, Kentucky
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
📍 California Research Institute — Los Angeles, California
Triple Negative Breast Cancer
View Study & Checklist ➔Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy
📍 Emory University Hospital Midtown — Atlanta, Georgia
Advanced Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)
📍 Ironwood Cancer & Research Centers — Chandler, Arizona
Melanoma
View Study & Checklist ➔I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
📍 University of Alabama at Birmingham — Birmingham, Alabama
Breast Neoplasms
View Study & Checklist ➔Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
📍 Lombardi Comprehensive Cancer Center, Georgetown University — Washington D.C., District of Columbia
Non-small Cell Lung Cancer Stage III
View Study & Checklist ➔A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers
📍 Massachusetts General Hospital — Boston, Massachusetts
Epithelial Ovarian Cancer
View Study & Checklist ➔Gemcitabine, Cisplatin, Nab-paclitaxel (GAP) and Cemiplimab for Locally Advanced Biliary Tract Cancer (BTC)
📍 Columbia University Irving Medical Center — New York, New York
Colon and Rectal Cancer
View Study & Checklist ➔Cemiplimab Plus Gemcitabine in Patients With Metastatic Pancreatic Adenocarcinoma
📍 University of California, San Diego — La Jolla, California
Pancreatic Ductal Adenocarcinoma (mPDAC)
View Study & Checklist ➔A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
View Study & Checklist ➔Chemo4METPANC Combination Chemokine Inhibitor, Immunotherapy, and Chemotherapy in Pancreatic Adenocarcinoma
📍 Columbia University Irving Medical Center — New York, New York
Pancreatic Cancer
View Study & Checklist ➔Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer
📍 The University of Alabama at Birmingham — Birmingham, Alabama
Ovarian Cancer
View Study & Checklist ➔A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
📍 University of Florida — Gainesville, Florida
Colo-rectal Cancer
View Study & Checklist ➔A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
📍 City of Hope Comprehensive Cancer Center — Duarte, California
Ovarian Cancer
View Study & Checklist ➔A Study Comparing Two Immunotherapy Options for Human Papillomavirus Positive HPV-Positive Head and Neck Cancer After Treatment
📍 The University of Chicago — Chicago, Illinois
Head and Neck Cancer
View Study & Checklist ➔Study of Cemiplimab Plus Ziv-Aflibercept for Subjects With Metastatic Uveal Melanoma
📍 The Angeles Clinic and Research Institute — Los Angeles, California
Metastatic Uveal Melanoma
View Study & Checklist ➔Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
📍 University of Alabama_6th Ave — Birmingham, Alabama
Recurrent Ovarian Cancer
View Study & Checklist ➔Phase I Study of Tolododekin Alfa (ANK-101) in Advanced Solid Tumors
📍 National Cancer Institute — Bethesda, Maryland
Advanced Solid Tumor
View Study & Checklist ➔XL092 and Cemiplimab in BRAF WT Thyroid Cancer
📍 Dana Farber/Harvard Cancer Center — Boston, Massachusetts
Anaplastic Thyroid Cancer
View Study & Checklist ➔Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
📍 Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
Recurrent Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
📍 Site-113 — Duarte, California
Solid Tumor
View Study & Checklist ➔Thoracic Radiotherapy and Inhibition of PD-1 and LAG-3 for Locally Advanced Non-Small Cell Lung Cancer
📍 Montefiore Einstein Comprehensive Cancer Center (MECCC) — The Bronx, New York
NSCLC
View Study & Checklist ➔Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT)
📍 Columbia University Irving Medical Center/ New York Presbyterian Hospital — New York, New York
Bladder Cancer
View Study & Checklist ➔A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body
📍 USC Norris Comprehensive Cancer Center — Los Angeles, California
Melanoma
View Study & Checklist ➔Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Non-Small Cell Lung Cancer
View Study & Checklist ➔A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
📍 Scripps Clinic Torrey Pines — La Jolla, California
Multiple Myeloma
View Study & Checklist ➔Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma
📍 Northwestern University — Chicago, Illinois
Metastatic NUT Carcinoma
View Study & Checklist ➔Study of All-Trans Retinoic Acid (ATRA) and Cemiplimab in Patients With Advanced Leiomyosarcoma
📍 Ohio State University Comprehensive Cancer Center — Columbus, Ohio
Leiomyosarcoma
View Study & Checklist ➔Preoperative Radioimmunotherapy Versus Chemoimmunotherapy in NSCLC
📍 Weill Cornell Medicine — New York, New York
Carcinoma, Non-Small-Cell Lung
View Study & Checklist ➔A Study of Cemiplimab With Chemotherapy and Immunotherapy in People With Head and Neck Cancer
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Head and Neck Cancer
View Study & Checklist ➔Testing the Addition of Cemiplimab (REGN2810) to Chemotherapy Treatment Given Prior to Surgery in Patients With Sinonasal Squamous Cell Carcinoma
📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California
Sinonasal Squamous Cell Carcinoma
View Study & Checklist ➔5-Azacitidine Plus PD-1/PD-L1 Inhibitor With PD-1/PD-L1 Refractory Tumors
📍 University of Iowa Health Care — Iowa City, Iowa
Solid Tumor
View Study & Checklist ➔Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
📍 Mayo Clinic in Rochester — Rochester, Minnesota
Lung Non-Small Cell Carcinoma
View Study & Checklist ➔A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
B-Cell Non-Hodgkin Lymphoma
View Study & Checklist ➔A Study of Fianlimab, Cemiplimab, and Ipilimumab in People With Melanoma
📍 Cedars-Sinai Medical Center — Los Angeles, California
Advanced Melanoma
View Study & Checklist ➔Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
Peripheral T Cell Lymphoma
View Study & Checklist ➔Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma
📍 Moffitt Cancer Center — Tampa, Florida
Merkel Cell Carcinoma
View Study & Checklist ➔Cemiplimab and Transarterial Radioembolization With Y-90 SIR-S Spheres for the Treatment of Liver Directed Metastatic Breast Cancer
📍 City of Hope Medical Center — Duarte, California
Anatomic Stage IV Breast Cancer AJCC v8
View Study & Checklist ➔Cemiplimab and Cetuximab Prior Salvage Surgery in Patients With Recurrent Oral Cavity and HPV-negative Oropharyngeal Squamous Cell Carcinoma
📍 MD Anderson Cancer Center — Houston, Texas
Locally Recurrent Oral Cavity Squamous Cell Carcinoma
View Study & Checklist ➔Trial of Cemiplimab, or Cemip-Chemo Followed by Biomarker-guided Treatment for Pts w/HPV H&N Ca
📍 Johns Hopkins University — Baltimore, Maryland
HPV-Related Squamous Cell Carcinoma
View Study & Checklist ➔Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets
📍 St. Joseph's Hospital and Medical Center — Phoenix, Arizona
Brain Tumor
View Study & Checklist ➔Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
📍 Johns Hopkins SKCCC — Baltimore, Maryland
Colorectal Cancer
View Study & Checklist ➔